---
layout: post
title:     Precision Medicine Rogue Therapeutics Harvard 
---


<!DOCTYPE html><html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"><title>Precision Medicine- Rogue Therapeutics Harvard 2016</title><meta name="description" content="Rare disease, genomics and patient-driven medicine may be terms that you have never heard of. All of these terms relate to precision…"><style>
      * {
        font-family: Georgia, Cambria, "Times New Roman", Times, serif;
      }
      html, body {
        margin: 0;
        padding: 0;
      }
      h1 {
        font-size: 50px;
        margin-bottom: 17px;
        color: #333;
      }
      h2 {
        font-size: 24px;
        line-height: 1.6;
        margin: 30px 0 0 0;
        margin-bottom: 18px;
        margin-top: 33px;
        color: #333;
      }
      h3 {
        font-size: 30px;
        margin: 10px 0 20px 0;
        color: #333;
      }
      header {
        width: 640px;
        margin: auto;
      }
      section {
        width: 640px;
        margin: auto;
      }
      section p {
        margin-bottom: 27px;
        font-size: 20px;
        line-height: 1.6;
        color: #333;
      }
      section img {
        max-width: 640px;
      }
      footer {
        padding: 0 20px;
        margin: 50px 0;
        text-align: center;
        font-size: 12px;
      }
      .aspectRatioPlaceholder {
        max-width: auto !important;
        max-height: auto !important;
      }
      .aspectRatioPlaceholder-fill {
        padding-bottom: 0 !important;
      }
      header,
      section[data-field=subtitle] {
        display: none;
      }
      </style></head><body><article class="h-entry">
<header>
<h1 class="p-name">Precision Medicine- Rogue Therapeutics Harvard 2016</h1>
</header>
<section data-field="subtitle" class="p-summary">
Rare disease, genomics and patient-driven medicine may be terms that you have never heard of. All of these terms relate to precision…
</section>
<section data-field="body" class="e-content">
<section name="93e8" class=" section--body section--first section--last"><div class="section-divider layoutSingleColumn"><hr class="section-divider"></div><div class="section-content"><div class="section-inner layoutSingleColumn"><h3 name="d5db" id="d5db" class="graf--h3 graf--leading graf--title">Precision Medicine- Rogue Therapeutics Harvard 2016</h3><figure name="2f28" id="2f28" class="graf--figure graf-after--h3"><div class="aspectRatioPlaceholder is-locked" style="max-width: 650px; max-height: 193px;"><div class="aspectRatioPlaceholder-fill" style="padding-bottom: 29.7%;"></div><img class="graf-image" data-image-id="1*VX3V6yKYrDpmtF54IMM6_A.png" data-width="650" data-height="193" src="https://d262ilb51hltx0.cloudfront.net/max/800/1*VX3V6yKYrDpmtF54IMM6_A.png"></div></figure><p name="36d7" id="36d7" class="graf--p graf-after--figure">Rare disease, genomics and patient-driven medicine may be terms that you have never heard of. All of these terms relate to <a href="https://en.wikipedia.org/wiki/Precision_medicine" data-href="https://en.wikipedia.org/wiki/Precision_medicine" class="markup--anchor markup--p-anchor">precision medicine</a>, medical treatments that are tailored to a specific patient.</p><p name="e351" id="e351" class="graf--p graf-after--p">These patients usually have some sort of rare disease, which is any disease that affects l<a href="https://globalgenes.org/rare-diseases-facts-statistics/" data-href="https://globalgenes.org/rare-diseases-facts-statistics/" class="markup--anchor markup--p-anchor">ess than 200,000</a> people (in the United States). However, while the diseases themselves may be rare; having a rare disease is <em class="markup--em markup--p-em">not</em> <em class="markup--em markup--p-em">rare</em>. There are approximately <a href="https://globalgenes.org/rare-diseases-facts-statistics/" data-href="https://globalgenes.org/rare-diseases-facts-statistics/" class="markup--anchor markup--p-anchor">30 million</a> people in the United States that suffer from a rare disease.</p><h4 name="96de" id="96de" class="graf--h4 graf-after--p">What is the purpose of precision medicine?</h4><p name="4f18" id="4f18" class="graf--p graf-after--h4">The goal of precision medicine is to develop treatments to alleviate rare diseases. The range of treatments available are quite limited because <a href="https://globalgenes.org/rare-diseases-facts-statistics/" data-href="https://globalgenes.org/rare-diseases-facts-statistics/" class="markup--anchor markup--p-anchor">80% of rare disease</a> are genetic based. This means that while traditional medications could treat rare diseases, they will never permanently <em class="markup--em markup--p-em">cure</em> genetic disorders.</p><h4 name="2cc4" id="2cc4" class="graf--h4 graf-after--p">Undiagnosed Disease Network</h4><p name="619b" id="619b" class="graf--p graf-after--h4">Even though Precision Medicine as a discipline is still in its infant stages, there are many organizations that aim to make precision medicine available to every patient. One such organization is the <a href="https://undiagnosed.hms.harvard.edu/" data-href="https://undiagnosed.hms.harvard.edu/" class="markup--anchor markup--p-anchor">Undiagnosed Disease Network</a> (UDN). This is an initiative funded by the <a href="https://www.nih.gov/" data-href="https://www.nih.gov/" class="markup--anchor markup--p-anchor">NIH</a> to aid those with rare diseases to have a diagnosis. While only <a href="https://globalgenes.org/rare-diseases-facts-statistics/" data-href="https://globalgenes.org/rare-diseases-facts-statistics/" class="markup--anchor markup--p-anchor">50% of the current existing rare diseases</a> have a foundation studying and supporting patients with that disease (let alone a cure or treatment for that disease), the UDN can help patients towards a diagnosis.</p><h4 name="8c56" id="8c56" class="graf--h4 graf-after--p">Karen, Ornella &amp; Lysogene</h4><p name="5a95" id="5a95" class="graf--p graf-after--h4">Another example of an organization that supports rare diseases and have successfully produced one form of precision medicine (so far) is <a href="http://www.lysogene.com/" data-href="http://www.lysogene.com/" class="markup--anchor markup--p-anchor">Lysogene</a>. This company was founded by a mother, Karen Aiach, whose daughter, Ornella, was diagnosed with <a href="https://www.nlm.nih.gov/medlineplus/ency/article/001210.htm" data-href="https://www.nlm.nih.gov/medlineplus/ency/article/001210.htm" class="markup--anchor markup--p-anchor">Sanfilippo Syndrome</a>. At the time of diagnosis the doctors stated that the prognosis of Ornella was highly dysfunctional childhood development and an early death at the age of 20 (if not earlier).</p><blockquote name="07ff" id="07ff" class="graf--blockquote graf--startsWithDoubleQuote graf-after--p">“There will be no cure for 20 years, go home and enjoy the time left with your child.” — The doctors diagnosing Ornella</blockquote><p name="9352" id="9352" class="graf--p graf-after--blockquote">In spite of the doctors’ prognosis, Karen was determined to do something about her daughter’s health condition. She did research and talked to the right people and eventually brought a treatment for Sanfilippo Syndrome to clinical trials. Her daughter still lives, and has given hope to other patients with Sanfilippo Syndrome.</p><p name="2ce4" id="2ce4" class="graf--p graf-after--p">Unfortunately Karen and Ornella’s story is still rare when it comes to the rare disease community. There are thousands that die annually without any cure, or even any hope for a cure. This must change. As research progresses and discoveries about rare diseases are made, more cures will come. Karen, among others, are the pioneers of precision medicine. I hope for a time when all patients diagnosed with a rare disease will be as fortunate as Ornella.</p><p name="648a" id="648a" class="graf--p graf-after--p">You can read more about Karen and Ornella’s story <a href="http://labiotech.eu/karen-aiach-lysogene-interview-san-filippo/" data-href="http://labiotech.eu/karen-aiach-lysogene-interview-san-filippo/" class="markup--anchor markup--p-anchor">here at labiotech.eu</a>.</p><p name="48d2" id="48d2" class="graf--p graf-after--p graf--last">-Cole</p></div></div></section>
</section>
<footer><p>By <a href="https://medium.com/@colelyman" class="p-author h-card">Cole Lyman</a> on <a href="https://medium.com/p/1483ec4233ec"><time class="dt-published" datetime="2016-06-23T18:10:08.068Z">June 23, 2016</time></a>.</p><p>Exported from <a href="https://medium.com">Medium</a> on August 7, 2016.</p></footer></article>

</body></html>